The influence of royal jelly and human interferon-alpha (HuIFN-αN3) on proliferation, glutathione level and lipid peroxidation in human colorectal adenocarcinoma cells in vitro / Vpliv matičnega mlečka in humanega interferona-alfa (HuIFN-αN3) na proliferacijo, nivo glutationa in na preoksidacijo lipidov v humanih kolorektalnih adenokarcinomskih celicah in vitro

1. Ramadan FM, Al-Ghamdi. Bioactive compounds and healthpromoting properties of royal jelly: a review. J Funct Foods 2012;4:39-52. doi: 10.1016/j.jff.29.11.12.007Search in Google Scholar

2. Pavel IC, Margharitas AL, Bobis O, Dezmirean DS, Sapcaliu A, Radoi I, Madas NM. Biological activities of royal jelly - review. Anim Sci Biotechnol 2011;44:108-18.Search in Google Scholar

3. Tahashi K, Hiroshi M. Royal jelly acid 10-hydroxy-trans-2- decenoic acid as a modulator of the innate immune responses. Endocr Metab Immune Disord Drug Targets 2012;12:368-76. doi: 10.2174/18715301280383253010.2174/18715301280383253023061418Search in Google Scholar

4. Townsend GF, Morgan JF, Tolnai S, Hazlett B, Morton HJ, Shuel RW. Studies on the in vitro antitumor activity of atty acids. I. 10-Hdroxy-2-decenoic acid from royal jelly. Cancer Res 1960;20:503-10. PMID: 13839101Search in Google Scholar

5. Tamura T, Fuji A, Kuboyama N. [Antitumor effects of royal jelly (RJ), in Japanese]. Folia Pharmacol Japon 1987;89:73-80. doi: 10.1254/fpj.89.7310.1254/fpj.89.733570105Search in Google Scholar

6. Watanabe K, Shinmoto H, Kobori M, Tsushida T, Shinohara K, Kanaeda J, Yonekura M. Stimulation of cell growth in the U937 human myeloid cell line by honey royal jelly protein . Cytotechnology 1998 ; 26 : 23-7 . d o i : 10.1023/A:100792849812810.1023/A:1007928408128Search in Google Scholar

7. Salazar-Olivio LA, Paz-González V. Screening of biological activities present in honeybee (Apis mellifera) royal jelly. Toxicology in Vitro 2005;19:645-51. doi: 10.1016/j. tiv.2005.03.001Search in Google Scholar

8. Mocellin S, Lens MB, Pasquali S, Pilati P, Chiarion Sileni V. Interferon alpha for the adjuvant treatment of cutaneous melanoma. Cochrane Database Syst Rev 2013;6:CD008955. doi: 10.1002/14651858.CD00895510.1002/14651858.CD008955Search in Google Scholar

9. Kalliolias DG, Ivashkiv BL. Overview of the biology of type I interferons. Arthritis Res Ther 2010;12(Suppl 1):S1-9. doi: 10.1186/ar288110.1186/ar2881299177420392288Search in Google Scholar

10. Liu X, Lu J, He ML, Li Z, Zhang B, Zhou LH, Li Q, Li G, Wang L, Tian WD, Peng Y, Li XP. Antitumor effect of interferon alpha on cell growth and metastasis in human nasopharyngeal carcinoma. Curr Cancer Durg Targets 2013;12:561-70. doi: 10.2174/15680091280067329310.2174/15680091280067329322414012Search in Google Scholar

11. Jonasch E, Hluska GF. Interferon in oncological practice: review of interferon biology, clinical application and toxicities. Oncologist 2001;6:34-55. doi: 10.1634/ theoncologist.6-1-3410.1634/theoncologist.6-1-3411161227Search in Google Scholar

12. Jedema I, Barge RMY, Willemze R, Falkenburg JH. High suspectibility of human leukemic cells to Fas-induced apoptosis is restricted to G1 phase of the cell cycle and can be increased by interferon treatment. Leukemia 2003;17:576-84. doi: 10.1038/sj.leu.240284410.1038/sj.leu.240284412646947Search in Google Scholar

13. Peek SF, Bonds MD, Gangemi DG, Thomas CB, Schultz RD. Evaluation of cytotoxicity and antiviral activity of recombinant human interferon alfa-2a and recombinant human interferon alfa-B/D hybrid against bovine viral diarrhea virus, infectious bovine rhinotracheitis virus, and vesicular stomatitis virus in vitro. Am J Vet Res 2004;65:871-4. doi: 10.2460/avjr.2004.65.871Search in Google Scholar

14. Ziegler TR, Nkabyo SY, Gu LH, Watson WH, Jones DP. Glutathione and theredoxin during the differentiation in human colon epithelial (CaCo-2) cells. Am J Physiol Gastrointest Liver Physiol 2002;283:G1352-59. doi: 10.1152/ajpgi.00183.200210.1152/ajpgi.00183.200212433666Search in Google Scholar

15. Gago-Dominguez M, Jiang X, Castelao EJ. Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis. Breast Cancer Res 2007;9:201-11. doi: 10.1186/bcr162810.1186/bcr1628185140017224037Search in Google Scholar

16. Niki E, Yosida Y, Saito Y, Noguchi N. Lipid peroxidation: mechanism, inhibition and biological effects. Biochem Biophys Res Commun 2005;338:668-76. doi: 10.1016/j. bbrc.2005.08.072Search in Google Scholar

17. Fidler JI, Heicappel R, Saiki I, Grutter GM, Horisberger AM, Nuesch J. Direct antiproliferative effects of recombinant human interferon - α B/D hybrids on human tumor cell lines. Cancer Res 1987;47:2020-7. PMID: 3828990Search in Google Scholar

18. Yanagita M, Kojima Y, Mori K, Yamada S, Murakami S. Osteoinductive effect of royal jelly on periodontal ligament cells. Biomed Res 2011;32:285-91. doi: 10.220/ biomedres.32.28510.2220/biomedres.32.285Search in Google Scholar

19. Mihajlović D, Vučević D, Chinou J, Čolić M. Royal jelly fatty acid modulate proliferation and cytokine production by human peripheral blood mononuclear cells. Eur Food Res Technol 2014;238:881-7. doi: 10.1007/s00217-014-2154-710.1007/s00217-014-2154-7Search in Google Scholar

20. Borden EC, Hogan TF, Voekel JG. Comparative antiproliferative activity in vitro of natural interferons α and β for diploid and transformed human cells. Cancer Res 1982;42:4948-53. PMID: 7139598Search in Google Scholar

21. Buege JA, August SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-10. doi: 10.1016/S0076-6879(78)52032-610.1016/S0076-6879(78)52032-6Search in Google Scholar

22. Devasagayam TPA, Bloor KK, Ramasarma T. Methods for estimating the lipid peroxidation: an analysis of merits and demerits. Indian J Biochem Biophys 2003;40:300-8. PMID: 22900323Search in Google Scholar

23. Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, Pronzato A, Marinari UM, Domenicotti C. Role of gluthatione in cancer progression and chemoresistence. Oxid Med Cell Longev Volume 2013; Article ID 972913: doi: 10.1155/2013/97291310.1155/2013/972913367333823766865Search in Google Scholar

24. Karadeniz A, Simsek N, Karakus E, Yildirim S, Kara A, Can I, Kisa F, Emre H, Turkeli M. Royal jelly modulates oxidative stress and apoptosis in liver and kidneys of rats treated with cisplatin. Oxid Med Cell Longev 2011; Article ID 981793, doi: 10.1155/2011/98179310.1155/2011/981793316657921904651Search in Google Scholar

25. Merendino N, Loppi B, D’Aquino M, Molinari R, Pessino G, Romano C, Velotti F. Docohexaenoic acid induces apoptosis in the human PaCa-44 pancreatic cancer cell line by active reduced glutathione extrusion and lipid peroxidation. Nutr Cancer 2005;52:225-33. doi: 10.1207/ s15327914nc5202_1210.1207/s15327914nc5202_1216201853Search in Google Scholar

26. Eghdami A, Sohi HMS. Investigation of α-IFN-SWNT and α-IFN-PLGA effects on breast cancer in rats induced by DMBA by using CAIS-3 tumor marker. Adv Biores 2014;5:9-13.Search in Google Scholar

27. Swierenga HHS, Whitfield FJ, Karasakti S. Loss of proliferative calcium dependence: simple in vitro indicator of tumorigenicity. Proc Natl Acad Sci USA 1978;75:6069-72. doi: 10.1073/pnas.75.12.606910.1073/pnas.75.12.6069393119282624Search in Google Scholar

28. Thepot A, Desanlis A, Venet E, Thivillier L, Justin V, Morel AP, DeFraipont, Till M, Krutovskikh V, Tommasino M, Damour O, Hainaut P. Assesment of transformed properties in vitro and of tumorigenicity in vivo in primary keratinocytes cultured for epidermal sheet transplantation. J Skin Cancer Volume 2011, Article ID 936546, doi: 10.1155/2011/93654610.1155/2011/936546300398821188234Search in Google Scholar